Citation of paper, Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England

Authors Citing This Paper

AuthorCiting PapersAuthor's PapersAuthor's CitationsAuthor's IF
Gemma Shields1263862.6
Marta O Soares1369263.9
Holly L Cranmer13242.2
Rachael Batteson1271.8
Dong Churl Suh1524381.5
Andrew H Briggs134221,6246.1
Virginie Nerich1231731.7
Javier Cortes124316,73512.4
Ash Bullement1211712.6